Authors: Gautschi, O Tschopp, S Olie, RA Leech, SH Simoes-Wust, AP Ziegler, A Baumann, B Odermatt, B Hall, J Stahel, RA Zangemeister-Wittke, U

Citation: O. Gautschi et al., Activity of a novel bcl-2/bcl-xL-bispecific antisense oligonucleotide against tumors of diverse histologic origins, J NAT CANC, 93(6), 2001, pp. 463

Authors: Himmelmann, A Gautschi, O Nawrath, M Bolliger, U Fehr, J Stahel, RA

Citation: A. Himmelmann et al., Persistent polyclonal B-cell lymphocytosis is an expansion of functional IgD(+)CD27(+) memory B cells, BR J HAEM, 114(2), 2001, pp. 400-405

Authors: Zangemeister-Wittke, U Leech, SH Olie, RA Simoes-Wust, AP Gautschi, O Luedke, GH Natt, F Haner, R Martin, P Hall, J Nalin, CM Stahel, RA

Citation: U. Zangemeister-wittke et al., A novel bispecific antisense oligonucleotide inhibiting both bcl-2 and bcl-xL expression efficiently induces apoptosis in tumor cells, CLIN CANC R, 6(6), 2000, pp. 2547-2555

Authors: Simoes-Wust, AP Olie, RA Gautschi, O Leech, SH Haner, R Hall, J Fabbro, D Stahel, RA Zangemeister-Wittke, U

Citation: Ap. Simoes-wust et al., bcl-xL antisense treatment induces apoptosis in breast carcinoma cells, INT J CANC, 87(4), 2000, pp. 582-590

Authors: Leech, SH Olie, RA Gautschi, O Simoes-Wust, AP Tschopp, S Haner, R Hall, J Stahel, RA Zangemeister-Wittke, U

Citation: Sh. Leech et al., Induction of apoptosis in lung-cancer cells following bcl-xL anti-sense treatment, INT J CANC, 86(4), 2000, pp. 570-576